Literature DB >> 30672348

Bioactive injectable triple acting thermosensitive hydrogel enriched with nano-hydroxyapatite for bone regeneration: in-vitro characterization, Saos-2 cell line cell viability and osteogenic markers evaluation.

Nadia M Morsi1, Rehab Nabil Shamma1, Nouran Osama Eladawy1, Abdelfattah A Abdelkhalek2.   

Abstract

Hydrogels forming in-situ have gained great attention in the area of bone tissue engineering recently, they were also showed to be a good and less invasive alternative to surgically applied ones. The primal focus of this study was to prepare chitosan-glycerol phosphate thermosensitive hydrogel formed in-situ and loaded with risedronate (bone resorption inhibitor) in an easy way with no requirement of complicated processes or large number of equipment. Then we investigated its effectiveness for bone regeneration. In-situ forming hydrogels were prepared using chitosan cross-linked with glycerol phosphate and loaded with risedronate and nano-hydroxyapatite as bone cement. The prepared hydrogels were characterized by analyzing their gelation time at 37 °C, % porosity, swelling index, in-vitro degradation, rheological properties, and in-vitro drug release. Results showed that the in-situ hydrogels prepared using 2.5% (w/v) chitosan cross-linked with 50% (w/v) glycerol phosphate in the ratio (9:1, v/v) reinforced with 20 mg/mL and nano-hydroxyapatite possessed the most sustained drug release profile. This optimized formulation was further evaluated using DSC and FTIR studies, in addition to their morphological properties using scanning electron microscopy. The effect on Saos-2 cell line viability was evaluated also using MTT assay on the optimized hydrogel formulation in addition to their action on cell proliferation using fluorescence microscope. Moreover, calcium deposition on the hydrogel and alkaline phosphatase activity were evaluated. Risedronate-nano-hydroxyapatite loaded hydrogels significantly enhanced the Saos-2 cell proliferation in addition to enhanced alkaline phosphatase activity and calcium deposition. Such results suggest that risedronate-nano-hydroxyapatite loaded hydrogels present great biocompatibility for bone regeneration. Proliferation of cells, as well as deposition of mineral on the hydrogel, was an evidence of the biocompatible nature of the hydrogel. This hydrogel formed in-situ present a good less invasive alternative for bone tissue engineering.

Entities:  

Keywords:  Risedronate; Saos 2 cells; alkaline phosphatase; bone tissue engineering; chitosan

Mesh:

Substances:

Year:  2019        PMID: 30672348     DOI: 10.1080/03639045.2019.1572184

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  5 in total

Review 1.  From injectable to 3D printed hydrogels in maxillofacial tissue engineering: A review.

Authors:  Divya Mehrotra; Ruby Dwivedi; Deepti Nandana; R K Singh
Journal:  J Oral Biol Craniofac Res       Date:  2020-09-21

Review 2.  New Progress in Improving the Delivery Methods of Bisphosphonates in the Treatment of Bone Tumors.

Authors:  Yu Zhong; Su Li
Journal:  Drug Des Devel Ther       Date:  2021-12-10       Impact factor: 4.162

3.  Hyaluronic acid-enriched bilosomes: an approach to enhance ocular delivery of agomelatine via D-optimal design: formulation, in vitro characterization, and in vivo pharmacodynamic evaluation in rabbits.

Authors:  Asmaa Ashraf Nemr; Galal Mohamed El-Mahrouk; Hany Abdo Badie
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

4.  Incorporation of NGR1 promotes bone regeneration of injectable HA/nHAp hydrogels by anti-inflammation regulation via a MAPK/ERK signaling pathway.

Authors:  Yi Liu; Yifan Zhang; Zexiang Zheng; Wenchao Zhong; Haiyang Wang; Zhen Lin; Lihua Li; Gang Wu
Journal:  Front Bioeng Biotechnol       Date:  2022-09-23

5.  Investigation of the Potential of Nebivolol Hydrochloride-Loaded Chitosomal Systems for Tissue Regeneration: In Vitro Characterization and In Vivo Assessment.

Authors:  Noha Ibrahim Elsherif; Abdulaziz Mohsen Al-Mahallawi; Abdelfattah Ahmed Abdelkhalek; Rehab Nabil Shamma
Journal:  Pharmaceutics       Date:  2021-05-11       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.